-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Enanta Pharma, Maintains $18 Price Target

Benzinga·02/11/2025 12:10:37
Listen to the news
HC Wainwright & Co. analyst Ed Arce reiterates Enanta Pharma (NASDAQ:ENTA) with a Buy and maintains $18 price target.